Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
152.41B | 125.93B | 110.05B | 95.31B | 81.59B | Gross Profit |
84.66B | 73.82B | 63.01B | 52.74B | 40.95B | EBIT |
57.08B | 50.81B | 42.91B | 34.60B | 22.83B | EBITDA |
63.56B | 54.25B | 46.30B | 37.39B | 25.62B | Net Income Common Stockholders |
43.37B | 36.74B | 32.55B | 24.92B | 15.95B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
125.19B | 102.12B | 107.26B | 71.24B | 65.66B | Total Assets |
243.48B | 217.37B | 187.37B | 163.71B | 143.47B | Total Debt |
12.16B | 11.75B | 6.10B | 6.83B | 7.93B | Net Debt |
-113.03B | -90.36B | -101.17B | -64.41B | -57.73B | Total Liabilities |
48.40B | 56.24B | 40.89B | 42.92B | 43.73B | Stockholders Equity |
195.08B | 161.13B | 146.47B | 120.80B | 99.73B |
Cash Flow | Free Cash Flow | |||
31.79B | 14.37B | 42.88B | 11.50B | 19.94B | Operating Cash Flow |
36.92B | 21.79B | 46.95B | 14.63B | 22.28B | Investing Cash Flow |
-5.96B | -7.68B | -7.43B | -4.23B | -8.44B | Financing Cash Flow |
-15.97B | -22.48B | -9.98B | -6.96B | -6.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | $68.06B | 17.08 | 22.60% | 2.36% | 0.23% | -0.09% | |
74 Outperform | $12.08B | 57.76 | 16.14% | 0.59% | -18.33% | -11.92% | |
74 Outperform | $39.38B | 38.45 | 14.04% | 0.50% | -2.99% | -0.46% | |
73 Outperform | $50.25B | ― | -460.30% | ― | 30.24% | 27.61% | |
60 Neutral | $38.74B | ― | -51.45% | ― | 1.00% | -148.89% | |
60 Neutral | $2.04B | 12.48 | -220.61% | 7.35% | -0.69% | -31.96% | |
59 Neutral | $13.76B | 7.70 | -1.87% | 3.86% | 2.21% | -37.55% |